Across TCGA pan-cancer cohorts, VPS37D Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated VPS37D data layer compared with 19 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher VPS37D Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated VPS37D expression acts as an unfavorable survival marker.
UCEC are the cancer types where VPS37D Mutation most reproducibly stratifies survival.